Canada markets closed

Vigil Neuroscience, Inc. (VIGL)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
4.3300-0.0400 (-0.92%)
At close: 04:00PM EDT
4.2000 -0.13 (-3.00%)
After hours: 07:27PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close4.3700
Open4.2600
Bid4.3000 x 400
Ask4.3500 x 300
Day's Range4.0200 - 4.4200
52 Week Range2.4700 - 11.1100
Volume174,277
Avg. Volume166,253
Market Cap162.74M
Beta (5Y Monthly)1.95
PE Ratio (TTM)N/A
EPS (TTM)-2.1200
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est16.75
  • GlobeNewswire

    Vigil Neuroscience to Present in Upcoming June Investor Conferences

    WATERTOWN, Mass., May 30, 2024 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative diseases, today announced management’s participation at two upcoming investor conferences. Ivana Magovčević-Liebisch, Ph.D., J.D., President & Chief Executive Officer and David Gray, Ph.D., Chief Science Officer, will participate in a fireside chat at the Jefferies Global Healthcare

  • Zacks

    All You Need to Know About Vigil Neuroscience (VIGL) Rating Upgrade to Buy

    Vigil Neuroscience (VIGL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

  • GlobeNewswire

    Vigil Neuroscience to Present at The Citizens JMP Life Sciences Conference

    WATERTOWN, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative diseases, today announced that management will participate in a fireside chat at the Citizens JMP Life Sciences Conference on Tuesday, May 14th at 11:30 a.m. E.T. To register for the live event, please click here. The webcast will also be available on the Company’s website on the “E